Patents by Inventor Dimitrios Kontoyiannis

Dimitrios Kontoyiannis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230091323
    Abstract: Compositions and methods for making biocompatible articles are provided. A method includes preparing a 3D printable mixture and depositing successive layers of the mixture in a predetermined pattern to form a porous biocompatible article. The predetermined pattern has a porosity suitable for a bone or cartilage scaffold. Associated 3D printable compositions and porous articles made from the described methods are also described. The preparing a 3D printable mixture can comprise conjugating an alkyne-terminated polymer to a peptide to form a peptide-containing composite, or providing a mixture that comprises a ceramic material and a binder, and wherein the 3D printable mixture comprises from 50 wt. % to 80 wt. % of the ceramic material.
    Type: Application
    Filed: February 2, 2021
    Publication date: March 23, 2023
    Applicant: William Marsh Rice University
    Inventors: Antonios Georgios Mikos, Jason Liwei Guo, Luis Antonio Diaz-Gomez, Anthony John Melchiorri, Maryam Eugenia Elizondo, Gerry Lynn Koons, Panayiotis Dimitrios Kontoyiannis
  • Publication number: 20050187161
    Abstract: The present invention concerns novel methods of identifying peptide sequences that selectively bind to fungal surface molecules. The general method, Biopanning and Rapid Analysis of Selective Interactive Ligands (BRASIL) provides for rapid and efficient separation of phage that bind to fungal surface molecules. BRASIL may be used in a pre-selection procedure to subtract phage that bind non-specifically to a first target, before exposing the subtracted library to a second target. Certain embodiments concern peptides identified by BRASIL against fungal surface components and methods of use of such peptides for delivery of therapeutic agents or imaging agents or diagnosis or treatment of fungal pathogenesis such as Invasive Aspergillus (IA). Novel compositions and treatments for IA as well as other fungal infection in immunocompromised patients are also disclosed.
    Type: Application
    Filed: September 13, 2004
    Publication date: August 25, 2005
    Inventors: Dimitrios Kontoyiannis, Wadih Arap, Renata Pasqualini, Michail Lionakis, Johanna Lahdenranta